Pubblicazioni del gruppo in riviste internazionali negli ultimi 5 anni

1.     Marastoni D, Sicchieri M, Pizzini FB, Scartezzini A, Virla F, Turano E, Anni D, Bertolazzo M, Ziccardi S, Camera V, Tamanti A, Marini M, Lippi G, Bonetti B, Solomon AJ, Calabrese M. Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands. J Neurol. 2025 Feb 15;272(3):207.

2.     Pontillo G, Prados F, Wink AM, Kanber B, Bisecco A, Broeders TAA, Brunetti A, Cagol A, Calabrese M, Castellaro M, Cocozza S, Colato E, Collorone S, Cortese R, De Stefano N, Douw L, Enzinger C, Filippi M, Foster MA, Gallo A, Gonzalez-Escamilla G, Granziera C, Groppa S, Harbo HF, Høgestøl EA, Llufriu S, Lorenzini L, Martinez-Heras E, Messina S, Moccia M, Nygaard GO, Palace J, Petracca M, Pinter D, Rocca MA, Strijbis E, Toosy A, Valsasina P, Vrenken H, Ciccarelli O, Cole JH, Schoonheim MM, Barkhof F; MAGNIMS study group.Hum Brain Mapp. 2025 More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis. Jan;46(1):e70107.

3.     Pontillo G, Prados F, Colman J, et al, Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap. Neurology. 2024 Nov 26;103(10)

4.     Ziccardi S, Crescenzo F, Guandalini M, Caliskan G, Martinelli L, Tamanti A, Schiavi GM, Bajrami A, Marastoni D, Calabrese M. Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study. Brain Commun. 2024 Oct 12;6(6):

5.     Rocca MA, Preziosa P, Barkhof F, Brownlee W, Calabrese M, De Stefano N, Granziera C, Ropele S, Toosy AT, Vidal-Jordana À, Di Filippo M, Filippi M. Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis. Lancet Reg Health Eur. 2024 Aug 22;44:

6.     Visani V, Veronese M, Pizzini FB, Colombi A, Natale V, Marjin C, Tamanti A,Schubert JJ, Althubaity N, Bedmar-Gómez I, Harrison NA, Bullmore ET, Turkheimer FE; NIMA Consortium; Calabrese M, Castellaro M. ASCHOPLEX: A generalizable approach for the automatic segmentation of choroid plexus. Comput Biol Med. 2024Nov;182:109164.

7.     Filippetti M, Lugoboni L, Di Censo R, Degli Esposti L, Facciorusso S, Varalta V, Santamato A, Calabrese M, Smania N, Picelli A. Classification of upper limbspasticity patterns in patients with multiple sclerosis: a pilot observational study. J Rehabil Med. 2024 Aug 25;56:jrm40548.

8.     Ziccardi S, Tamanti A, Ruggieri C, Guandalini M, Marastoni D, Camera V,Montibeller L, Mazziotti V, Rossi S, Calderone M, Pizzini FB, Montemezzi S,Magliozzi R, Calabrese M. CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis

Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray MatteDamage. Neurol Neuroimmunol Neuroinflamm. 2024 Nov;11(6):e200301.

9.     Mazziotti V, Crescenzo F, Turano E, Guandalini M, Bertolazzo M, Ziccardi S,Virla F, Camera V, Marastoni D, Tamanti A, Calabrese M. The contribution oftumor necrosis factor to multiple sclerosis: a possible role in progressionindependent of relapse? J Neuroinflammation. 2024 Aug 21;21(1):209.

10.     Luchetti L, Prados F, Cortese R, Gentile G, Calabrese M, Mortilla M, DeStefano N, Battaglini M; Alzheimer's Disease Neuroimaging Initiative. Evaluationof cervical spinal cord atrophy using a modified SIENA approach. Neuroimage.2024 Sep;298:120775.

11.     Scalfari A, Traboulsee A, Oh J, Airas L, Bittner S, Calabrese M, GarciaDominguez JM, Granziera C, Greenberg B, Hellwig K, Illes Z, Lycke J, Popescu V,Bagnato F, Giovannoni G. Smouldering-Associated Worsening in Multiple Sclerosis:An International Consensus Statement on Definition, Biology, ClinicalImplications, and Future Directions. Ann Neurol. 2024 Nov;96(5):826-845.

12.     Marastoni D, Turano E, Tamanti A, Colato E, Pisani AI, Scartezzini A,Carotenuto S, Mazziotti V, Camera V, Anni D, Ziccardi S, Guandalini M, PizziniFB, Virla F, Mariotti R, Magliozzi R, Bonetti B, Steinman L, Calabrese M.Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability inEarly Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2024Sep;11(5):e200265.

13.     Ciccarelli O, Barkhof F, Calabrese M, De Stefano N, Eshaghi A, Filippi M,Gasperini C, Granziera C, Kappos L, Rocca MA, Rovira À, Sastre-Garriga J,Sormani MP, Tur C, Toosy AT; as the MAGNIMS Study Group. Using the ProgressionIndependent of Relapse Activity Framework to Unveil the PathobiologicalFoundations of Multiple Sclerosis. Neurology. 2024 Jul 9;103(1):e209444.

14.     Ziccardi S, Genova H, Colato E, Guandalini M, Tamanti A, Calabrese M. The neural substrates of social cognition deficits in newly diagnosed multiple sclerosis patients. Ann Clin Transl Neurol. 2024 Jul;11(7):1798-1808.

15.     Calabrese M, Preziosa P, Scalfari A, Colato E, Marastoni D, Absinta M,Battaglini M, De Stefano N, Di Filippo M, Hametner S, Howell OW, Inglese M, Lassmann H, Martin R, Nicholas R, Reynolds R, Rocca MA, Tamanti A, Vercellino M, Villar LM, Filippi M, Magliozzi R. Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis. Ann Neurol. 2024 Jul;96(1):1-20.

16.     Aprea MG, Schiavetti I, Portaccio E, Ballerini C, Bonavita S, Buscarinu M, Calabrese M, Cavalla P, Cellerino M, Cordioli C, Dattola V, De Biase S, De Meo E, Fantozzi R, Gallo A, Iasevoli L, Karabudak R, Landi D, Lorefice L, Moiola L, Ragonese P, Ruscica F, Sen S, Sinisi L, Signoriello E, Toscano S, Verrengia E, Siva A, Masciulli C, Sormani MP, Amato MP. Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis. Mult Scler. 2024May;30(6):707-713. d

17.     Visani V, Pizzini FB, Natale V, Tamanti A, Anglani M, Bertoldo A, Calabrese M,Castellaro M. Choroid plexus volume in multiple sclerosis can be estimated on structural MRI avoiding contrast injection. Eur Radiol Exp. 2024 Feb 27;8(1):33.

18.     Marastoni D, Foschi M, Eccher C, Crescenzo F, Mazziotti V, Tamanti A, Bajrami A, Camera V, Ziccardi S, Guandalini M, Bosello F, Anni D, Virla F, Turano E, Romoli M, Mariotti R, Pizzini FB, Bonetti B, Calabrese M. CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis. Front Immunol. 2024 Feb 9;15:1343892. doi: 10.3389/fimmu.2024.1343892. PMID: 38404586; PMCID: PMC10885800.

19.     Bajrami A, Tamanti A, Peloso A, Ziccardi S, Guandalini M, Calderone M, Castellaro M, Pizzini FB, Montemezzi S, Marastoni D, Calabrese M. Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. J Neurol. 2024 Jan 30. doi: 10.1007/s00415-023-12179-y. Epub ahead of print. PMID: 38289534.

20.     Cagol A, Cortese R, Barakovic M, Schaedelin S, Ruberte E, Absinta M, Barkhof F, Calabrese M, Castellaro M, Ciccarelli O, Cocozza S, De Stefano N, Enzinger C, Filippi M, Jurynczyk M, Maggi P, Mahmoudi N, Messina S, Montalban X, Palace J, Pontillo G, Pr√∂bstel AK, Rocca MA, Ropele S, Rovira √Ä, Schoonheim MM, Sowa P, Strijbis E, Wattjes MP, Sormani MP, Kappos L, Granziera C; MAGNIMS Study Group. Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis. JAMA Neurol. 2024 Feb 1;81(2):143-153. doi: 10.1001/jamaneurol.2023.4737. PMID: 38079177; PMCID: PMC10714285.

21.     Ziccardi S, Fuchs T, Dwyer MG, Zivadinov R, Hulst HE, Calabrese M, Benedict RH. Cognitive phenotypes predict response to restorative cognitive rehabilitation in multiple sclerosis. Mult Scler. 2023 Nov 9:13524585231208331. doi: 10.1177/13524585231208331. Epub ahead of print. PMID: 37942544.

22.     Di Filippo M, Ferraro D, Ragonese P, Prosperini L, Maniscalco GT, Gallo A, Cavalla P, Lorefice L, Nociti V, Di Sabatino E, Clerico M, Guaschino C, Radaelli M, Fantozzi R, Buttari F, Laroni A, Gajofatto A, Calabrese M, Malucchi S, Paolicelli D, De Luca G, Tomassini V, Lanzillo R, Moccia M, Solaro C, Cocco E, Gasperini C, Tortorella C; RIREMS (Rising Researchers in MS) group. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose. J Neurol. 2024 Jan;271(1):24-31. doi: 10.1007/s00415-023-12034-0. Epub 2023 Nov 3. PMID: 37922069; PMCID: PMC10769943.

23.     Chisari CG, Bianco A, Brescia Morra V, Calabrese M, Capone F, Cavalla P, Chiavazza C, Comi C, Danni M, Filippi M, Iaffaldano P, Lanzillo R, Lo Fermo S, Lucisano A, Lugaresi A, Lus G, Marfia GA, Marinelli F, Mirabella M, Moiola L, Perin C, Realmuto S, Toscano S, Trojano M, Vecchio D, Patti F; Italian MS Registry. Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY). Neurotherapeutics. 2023 Oct;20(6):1696-1706. doi: 10.1007/s13311-023-01415-y.

24.     Noteboom S, van Nederpelt DR, Bajrami A, Moraal B, Caan MWA, Barkhof F, Calabrese M, Vrenken H, Strijbis EMM, Steenwijk MD, Schoonheim MM. Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR. J Neurol. 2023 Nov;270(11):5201-5210. doi: 10.1007/s00415-023-11870-4. Epub 2023 Jul 19. PMID: 37466663; PMCID: PMC10576669.

25.     Altieri M, Capuano R, Bisecco A, d'Ambrosio A, Risi M, Cavalla P, Vercellino M, Annovazzi P, Zaffaroni M, De Stefano N, Stromillo ML, D'Amico E, Zangh√¨ A, Buscarinu MC, Lanzillo R, De Luca G, Calabrese M, Lorefice L, Di Filippo M, Valentino P, Gajofatto A, Marfia GA, Fuiani A, Nociti V, Tedeschi G, Gallo A. Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey. Mult Scler Relat Disord. 2023 Sep;77:104870. doi: 10.1016/j.msard.2023.104870.

26.     Magliozzi R, Howell OW, Calabrese M, Reynolds R. Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis. Nat Rev Neurol. 2023 Aug;19(8):461-476. doi: 10.1038/s41582-023-00838-7.  

27.     Aprea MG, Schiavetti I, Portaccio E, Ballerini C, Battaglia MA, Bergamaschi R, Brichetto G, Bunul SD, Calabrese M, Capobianco M, Cavalla P, Celani MG, Clerico M, Cocco E, Comi G, Confalonieri P, Conte A, Cordioli C, De Luca G, De Rossi N, Filippi M, Gumes H, Immovilli P, Inglese M, Karabudak R, Landi D, Lanzillo R, L'Episcopo MR, Lorefice L, Mantero V, Marangoni S, Marfia GA,

28.     Masciulli C, Milano E, Moiola L, Orlandi R, Patti F, Perini P, Pesci I, Pucci E, Puthenparampil M, Radaelli M, Salvetti M, Sartori A, Scandellari C, Sen S, Siva A, Strumia S, Teatini F, Tedeschi G, Trojano M, Tutuncu M, Vaula G, Sormani MP, Amato MP; Musc-19 Study Group. Sars-CoV2 infection in pregnant women with multiple sclerosis. Mult Scler. 2023 Aug;29(9):1090-1098. doi:10.1177/13524585231176174.

29.     Camera V, Mariano R, Messina S, Menke R, Griffanti L, Craner M, Leite MI, Calabrese M, Meletti S, Geraldes R, Palace JA. Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease. Brain Commun. 2023 Apr 4;5(3):fcad107. doi: 10.1093/braincomms/fcad107. PMID: 37180990; PMCID: PMC10171455.

30.     Gajofatto A, Cardobi N, Gobbin F, Calabrese M, Turatti M, Benedetti MD. Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity. BMC Neurol. 2023 Mar 29;23(1):128. doi: 10.1186/s12883-023-03171-0. PMID: 36991352; PMCID: PMC10052832.

31.     Pezzini F, Pisani A, Mazziotti V, Marastoni D, Tamanti A, Borroni E, Magon S, Zinnhardt B, Magliozzi R, Calabrese M. Intrathecal versus Peripheral Inflammatory Protein Profile in MS Patients at Diagnosis: A Comprehensive Investigation on Serum and CSF. Int J Mol Sci. 2023 Feb 13;24(4):3768. doi:10.3390/ijms24043768. PMID: 36835179; PMCID: PMC9964553.

32.     Pitteri M, Vannucci M, Dapor C, Guandalini M, Daffin√† A, Marastoni D, Calabrese M. Prominent role of executive functioning on the Phonemic Fluency Test in people with multiple sclerosis. J Int Neuropsychol Soc. 2023 Nov;29(9):902-906. doi: 10.1017/S1355617723000139.

33.     Bouman PM, Noteboom S, Nobrega Santos FA, Beck ES, Bliault G, Castellaro M, Calabrese M, Chard DT, Eichinger P, Filippi M, Inglese M, Lapucci C, Marciniak A, Moraal B, Morales Pinzon A, M√ºhlau M, Preziosa P, Reich DS, Rocca MA, Schoonheim MM, Twisk JWR, Wiestler B, Jonkman LE, Guttmann CRG, Geurts JJG, Steenwijk MD. Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection. Radiology. 2023 Apr;307(2):e221425. doi: 10.1148/radiol.221425.

34.     Ziccardi S, Pisani AI, Schiavi GM, Guandalini M, Crescenzo F, Colombi A, Peloso A, Tamanti A, Bertolazzo M, Marastoni D, Calabrese M. Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year study. Eur J Neurol. 2023 May;30(5):1378-1388. doi: 10.1111/ene.15697.

35.     Ziccardi S, Pizzini FB, Guandalini M, Tamanti A, Cristofori C, Calabrese M. Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis. Bioengineering (Basel). 2022 Dec 29;10(1):41.

36.     Bosello F, Marastoni D, Pizzini FB, Zaffalon C, Zuliani A, Turri G, Mariott S, Bonacci E, Pedrotti E, Calabrese M. Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review. J Neuroimmunol. 2022 Dec 23;375:  

37.     Mazziotti V, Crescenzo F, Tamanti A, Dapor C, Ziccardi S, Guandalini M, Colombi A, Camera V, Peloso A, Pezzini F, Turano E, Marastoni D, Calabrese M. Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. Biomedicines. 2022 Nov 24;10(12):3034.

38.     Magliozzi R, Pedrinolla A, Rossi S, Stabile AM, Danese E, Lippi G, Schena F, Calabrese M, Venturelli MV. Chronic Bedridden Condition Is Reflected by Substantial Changes in Plasma Inflammatory Profile. Biomolecules. 2022 Dec 13;12(12):1867.

39.     Ponzano M, Schiavetti I, Bergamaschi R, Pisoni E, Bellavia A, Mallucci G, Carmisciano L, Inglese M, Cordioli C, Marfia GA, Cocco E, Immovilli P, Pesci I, Scandellari C, Cavalla P, Radaelli M, Vianello M, Vitetta F, Montepietra S, Amato MP, Fioretti C, Filippi M, Sartori A, Caleri F, Clerico M, Gallo A, Conte A, Clerici R, De Luca G, Boneschi FM, Cantello R, Calabrese M, Tortorella C,Rovaris M, Verrengia EP, Patti F, Morra VB, Salvetti M, Sormani MP; MuSC-19 Study Group. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study. Mult Scler Relat Disord. 2022 Dec;68:104243.

40.     Andretta E, Finazzi Agrò E, Calabrese M, Orecchia L, Furlan A, Zuliani C. Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real- life data. Ther Adv Urol. 2022 Sep 24;

41.     Meaton I, Altokhis A, Allen CM, Clarke MA, Sinnecker T, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Granziera C, Kappos L, Montalban X, Rovira À, Wuerfel J, Evangelou N. Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis. Mult Scler. 2022 Dec;28(14):2212-2220.

42.     Baroncini D, Ghezzi A, Guaschino C, Moiola L, Filippi M, Ianniello A, Pozzilli C, Lanzillo R, Brescia-Morra V, Margoni M, Gallo P, Callari G, Grimaldi L, Lus G, Calabrese M, Simone M, Marfia GA, Rasia S, Cargnelutti D, Comi G, Zaffaroni M; MS Study Group of the Italian Neurological Society. Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study. Neurol Sci. 2022 Nov;43(11):6415-6423.

43.     James Bates RE, Browne E, Schalks R, Jacobs H, Tan L, Parekh P, Magliozzi R, Calabrese M, Mazarakis ND, Reynolds R. Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration. Brain. 2022 Dec 19;145(12):4287-4307.

44.     Marastoni D, Crescenzo F, Pisani AI, Zuco C, Schiavi G, Benedetti G, Ricciardi GK, Montemezzi S, Pizzini FB, Tamanti A, Calabrese M. Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis. Mult Scler. 2022 Nov;28(13):2090-2098.

45.     Marastoni D, Pisani AI, Schiavi G, Mazziotti V, Castellaro M, Tamanti A, Bosello F, Crescenzo F, Ricciardi GK, Montemezzi S, Pizzini FB, Calabrese M. CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis. Ther Adv Neurol Disord. 2022 Jun 21;

46.     Magliozzi R, Fadda G, Brown RA, Bar-Or A, Howell OW, Hametner S, Marastoni D, Poli A, Nicholas R, Calabrese M, Monaco S, Reynolds R. "Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis. Ann Neurol. 2022 Oct;92(4):670-685.

47.     Guerrera G, Mandelli A, Finardi A, Orrico M, D'Orso S, Picozza M, Noviello M, Beretta V, Bonetti B, Calabrese M, Marastoni D, De Rossi N, Capra R, Salvetti M, Buscarinu MC, Inglese M, Uccelli A, Moiola L, Raposo C, Muros-Le Rouzic E, Pedotti R, Filippi M, Bonini C, Battistini L, Borsellino G, Furlan R. Anti-SARS- CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients. Mult Scler. 2022 Oct;28(12):1937-1943.

48.     Pitteri M, Dapor C, DeLuca J, Chiaravalloti ND, Marastoni D, Calabrese M.Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients. J Int Neuropsychol Soc. 2022 Apr 25:1-7.  

49.     Buonomo AR, Viceconte G, Calabrese M, et al. Raising Italian Researchers in Multiple Sclerosis (RIREMS) study group. Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study. J Neurol. 2022 Jun;269(6):3301-3307.

50.     Ziccardi S, Crescenzo F, Calabrese M. "What Is Hidden behind the Mask?"Facial Emotion Recognition at the Time of COVID-19 Pandemic in Cognitively Normal Multiple Sclerosis Patients. Diagnostics (Basel). 2021 Dec 27;12(1):47.

51.     Cerea S, Ghisi M, Pitteri M, Guandalini M, Strober LB, Scozzari S, Crescenzo F, Calabrese M. Coping Strategies and Their Impact on Quality of Life and Physical Disability of People with Multiple Sclerosis. J Clin Med. 2021 Nov 29;10(23):5607.

52.     Sormani MP, Schiavetti I, Carmisciano L, Cordioli C, Filippi M, Radaelli M, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Cocco E, Scandellari C,Cavalla P, Pesci I, Zito A, Confalonieri P, Marfia GA, Perini P, Inglese M, Trojano M, Brescia Morra V, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; MuSC-19 Study Group. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):

53.     Marastoni D, Magliozzi R, Bolzan A, Pisani AI, Rossi S, Crescenzo F,Montemezzi S, Pizzini FB, Calabrese M. CSF Levels of CXCL12 and Osteopontin asEarly Markers of Primary Progressive Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021 Sep 29;8(6):e1083.

54.     Di Filippo M, Cordioli C, Malucchi S, Annovazzi P, Cavalla P, Torri Clerici V, Ragonese P, Nociti V, Radaelli M, Laroni A, Buttari F, Lorefice L, Ferraro D, Gajofatto A, Prosperini L, Fantozzi R, Boffa L, Lanzillo R, Moccia M, Clerico M,De Luca G, Tomassini V, Calabrese M, Borrelli A, Paolicelli D, Maniscalco GT, Gazzola P, Gallo A, Solaro C, Cocco E, Gasperini C, Tortorella C; RIREMS (Rising Researchers in MS) group. mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2021 Aug 18

55.     Bajrami A, Magliozzi R, Pisani AI, Pizzini FB, Crescenzo F, Marastoni D,Calabrese M. Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS. Mult Scler. 2021 Aug

56.     Magliozzi R, Pezzini F, Pucci M, Rossi S, Facchiano F, Marastoni D Montagnana M, Lippi G, Reynolds R, Calabrese M. Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation. Cells. 2021 Jul 6;10(7):1712.

57.     Sormani MP, Schiavetti I, Landi D, Carmisciano L, De Rossi N, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Brescia Morra V, Trojano M, Tedeschi G, Comi G, Battaglia MA, Patti F, Fragoso YD, Sen S, Siva A, Furlan R, Salvetti M; MuSC-19 Study Group. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study. Mult Scler. 2021 Jul 30:

58.     Pitteri M, Magliozzi R, Nicholas R, Ziccardi S, Pisani AI, Pezzini F, Marastoni D, Calabrese M. Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients. Mult Scler. 2021 Jul 30:

59.     Sormani MP, Salvetti M, Labauge P, Schiavetti I, Zephir H, Carmisciano L,Bensa C, De Rossi N, Pelletier J, Cordioli C, Vukusic S, Moiola L, Kerschen P, Radaelli M, Théaudin M, Immovilli P, Casez O, Capobianco M, Ciron J, Trojano M, Stankoff B, Créange A, Tedeschi G, Clavelou P, Comi G, Thouvenot E, Battaglia MA, Moreau T, Patti F, De Sèze J, Louapre C; Musc-19; Covisep study groups. DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France. Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744.

60.     Pitteri M, Galazzo IB, Brusini L, Cruciani F, Dapor C, Marastoni D, Menegaz G, Calabrese M. Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter. Diagnostics (Basel). 2021 Jun 16;11(6):1103.

61.     Boscolo Galazzo I, Brusini L, Akinci M, Cruciani F, Pitteri M, Ziccardi S, Bajrami A, Castellaro M, Salih AMA, Pizzini FB, Jovicich J, Calabrese M, Menegaz G. Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes. J Magn Reson Imaging. 2022 Jan;55(1):154-163.

62.     Cruciani F, Brusini L, Zucchelli M, Retuci Pinheiro G, Setti F, Boscolo Galazzo I, Deriche R, Rittner L, Calabrese M, Menegaz G. Interpretable deep learning as a means for decrypting disease signature in multiple sclerosis. J Neural Eng. 2021 Jul 19;18(4).

63.     Messina S, Mariano R, Roca-Fernandez A, Cavey A, Jurynczyk M, Leite MI, Calabrese M, Jenkinson M, Palace J. Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis. Mult Scler. 2022 Feb;28(2):217-227.

64.     Granziera C, Wuerfel J, Barkhof F, Calabrese M, De Stefano N, Enzinger C, Evangelou N, Filippi M, Geurts JJG, Reich DS, Rocca MA, Ropele S, Rovira À, Sati P, Toosy AT, Vrenken H, Gandini Wheeler-Kingshott CAM, Kappos L; MAGNIMS Study Group. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain. 2021 Jun 22;144(5):1296-1311.

65.     Crescenzo F, Marastoni D, Pisani AI, Tamanti A, Dapor C, Colombi A, Brillo A, Magliozzi R, Pizzini FB, Castellaro M, Calabrese M. The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study. Diagnostics (Basel). 2021 Apr 12;11(4):686.

66.     Ferraro D, Annovazzi P, Lanzillo R, Calabrese M, Fantozzi R, De Luca G, Cordioli C, Paolicelli D, Ragonese P, Gajofatto A, Lo Fermo S, Cavalla P, Tortorella C, Pesci I, Gallo A, Pinardi F, Di Filippo M, Maniscalco GT, Nociti V, Radaelli M, Tomassini V, Buscarinu MC, Moccia M, Camera V, Cocco E, Gasperini C, Solaro C. A multicenter survey on access to care in Multiple Sclerosis- related trigeminal neuralgia. J Neurol Sci. 2021 May 15;424:117430.

67.     Pisani AI, Scalfari A, Crescenzo F, Romualdi C, Calabrese M. A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients. Eur J Neurol. 2021 Apr 9.

68.     Pitteri M, Dapor C, Ziccardi S, Guandalini M, Meggiato R, Calabrese M. A Videogame-Based Approach to Measuring Information Processing Speed in Multiple Sclerosis Patients. Games Health J. 2021 Apr;10(2):115-120

69.     Ziccardi S, Pitteri M, Genova HM, Calabrese M. Social Cognition in Multiple Sclerosis: A 3-Year Follow-Up MRI and Behavioral Study. Diagnostics (Basel). 2021 Mar 9;11(3):484.

70.     Calabrese M, Marastoni D, Crescenzo F, Scalfari A. Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients. Curr Opin Neurol. 2021 Jun 1;34(3):277-285

71.     Magliozzi R, Pitteri M, Ziccardi S, Pisani AI, Montibeller L, Marastoni D, Rossi S, Mazziotti V, Guandalini M, Dapor C, Schiavi G, Tamanti A, Nicholas R, Reynolds R, Calabrese M. CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis. Ann Clin Transl Neurol. 2021 Mar;8(3):534-547

72.     Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Trojano M, Zaratin P, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; Musc-19 Study Group. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. Ann Neurol. 2021 Apr;89(4):780-789.

73.     Masuccio FG, Gamberini G, Calabrese M, Solaro C. Imaging and depression in multiple sclerosis: a historical perspective. Neurol Sci. 2021 Mar;42(3):835-845.

74.     Castellaro M, Tamanti A, Pisani AI, Pizzini FB, Crescenzo F, Calabrese M. The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysis. Diagnostics (Basel). 2020 Nov 29;10(12):1025.

75.     Pitteri M, Dapor C, Ziccardi S, Guandalini M, Meggiato R, Calabrese M. Visual-Attentional Load Unveils Slowed Processing Speed in Multiple Sclerosis Patients: A Pilot Study with a Tablet-Based Videogame. Brain Sci. 2020 Nov 18;10(11):871.

76.     Magliozzi R, Mazziotti V, Montibeller L, Pisani AI, Marastoni D, Tamanti A, Rossi S, Crescenzo F, Calabrese M. Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients. Front Cell Neurosci. 2020 Oct 16;14:569827.

77.     Magliozzi R, Marastoni D, Calabrese M. The BAFF / APRIL system as therapeutic target in multiple sclerosis. Expert Opin Ther Targets. 2020 Sep 8.

78.     Crescenzo F, Marastoni D, Bovo C, Calabrese M. Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy. Mult Scler Relat Disord. 2020 Jul 4;44:102372.

79.     Zanoni M, Orlandi E, Rossetti G, Turatti M, Calabrese M, Gomez Lira M, Gajofatto A. Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients. Acta Neurol Scand. 2020 May 20.

80.     Magliozzi R, Scalfari A, Pisani AI, Ziccardi S, Marastoni D, Pizzini FB, Bajrami A, Tamanti A, Guandalini M, Bonomi S, Rossi S, Mazziotti V, Castellaro M, Montemezzi S, Rasia S, Capra R, Pitteri M, Romualdi C, Reynolds R, CalabreseM. The CSF Profile Linked to Cortical Damage Predicts Multiple Sclerosis Activity. Ann Neurol. 2020 May 17.  

81.     Pitteri M, Vannucci M, Ziccardi S, Beccherle M, Semenza C, Calabrese M. False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm. Mult Scler Relat Disord. 2020 Jan;37:101418.